NEW YORK--(BUSINESS WIRE)--Nov. 15, 2016-- Piper Jaffray Companies (NYSE: PJC), a leading investment bank and asset management firm, will host its 28th annual Healthcare Conference in New York on November 29-30, 2016.

The Piper Jaffray Healthcare Conference will showcase senior management teams from nearly 300 leading public and private companies delivering presentations to an audience of nearly 2,000, including institutional investors, equity portfolio managers and research analysts. The two-day event will also host more than 3,600 private one-on-one meetings with company management. Presenting companies represent several healthcare sectors, including: biotechnology, medical services, specialty pharmaceuticals, medical technology, and life sciences tools and diagnostics.

Highlighting the conference will be several panel discussions featuring industry experts, physicians and academicians moderated by Piper Jaffray healthcare senior research analysts:

• Underdiscovered Neuro-Innovators Panel
  Moderated by Charles Duncan, Ph.D.
• Political Panel
  Moderated by Matt O’Brien, Bill Quirk and Brooks West
• Oncolytic Virus Panel: Gene Therapy Meets Cancer Immunotherapy Panel
  Moderated by Josh Schimmer, M.D.
• Underdiscovered Platform-Enabled Drug Developers Panel
  Moderated by Charles Duncan, Ph.D.
• Gene Therapy: The NAV Masters Panel
  Moderated by Josh Schimmer, M.D.
• Genomics 3.0: The Third Wave of Gene Targeting Therapies is Coming Panel
  Moderated by Josh Schimmer, M.D.
• Healthcare Executive Panel
  Moderated by Matt O’Brien and Brooks West

“As a frontrunner in the healthcare industry, our goal at the conference is to help investors navigate this evolving sector in the context of a regulatory and market landscape that continues to shift,” said Michael Cox, director of equity research at Piper Jaffray. “By bringing together hundreds of leading healthcare companies, we are able to provide our clients with a unique and exclusive experience.”

Follow the conversation using the event hashtag #PJCHCC16

Company and investor participation in the conference is by invitation only. Clients interested in attending should contact their Piper Jaffray representative. General and research-related media inquiries should be directed to analystmediarelations@pjc.com. All other media inquiries should be directed to Pamela Steensland at pamela.k.steensland@pjc.com.

Information as of November 14, 2016. Subject to change.

About Piper Jaffray
Piper Jaffray Companies (NYSE: PJC) is a leading investment bank and asset management firm. Securities brokerage and investment banking services are offered in the U.S. through Piper Jaffray & Co., member SIPC and FINRA; in Europe through Piper Jaffray Ltd. and Simmons & Company International Limited, authorized and regulated by the U.K. Financial Conduct Authority; and in Hong Kong through Piper Jaffray Hong Kong Limited, authorized and regulated by the Securities and Futures Commission. Asset management products and services are offered through five separate investment advisory affiliates―U.S. Securities and Exchange Commission (SEC) registered Advisory Research, Inc., Piper Jaffray Investment Management LLC, PJC Capital Partners LLC and Piper Jaffray & Co.; and Guernsey-based Parallel General Partners Limited, authorized and regulated by the Guernsey Financial Services Commission.

© 2016 Piper Jaffray Companies. 800 Nicollet Mall, Suite 1000, Minneapolis, Minnesota 55402-7036

Follow Piper Jaffray: LinkedIn | Facebook | Twitter

View source version on businesswire.com: http://www.businesswire.com/news/home/20161115006621/en/

Source: Piper Jaffray Companies

Piper Jaffray Companies
Pamela Steensland, 612-303-8185
pamela.k.steensland@pjc.com